华邦生命健康股份有限公司关于公司董事减持计划期限届满暨实施结果的公告

Core Viewpoint - The announcement details the completion of a share reduction plan by a director of Huabang Health, confirming that the plan was executed within the stipulated timeframe and did not exceed the planned reduction amount [1][2]. Group 1: Share Reduction Plan - The director, Mr. Wang Rong, planned to reduce his holdings by up to 2,700,000 shares, representing 0.1369% of the company's total share capital, during the period from August 19, 2025, to November 18, 2025 [1]. - The reduction was executed at a price range of 4.900 to 5.350 yuan per share [1]. Group 2: Compliance and Impact - The share reduction plan complied with relevant laws and regulations, including the Securities Law and the Shenzhen Stock Exchange listing rules [2]. - The implementation of the share reduction plan will not lead to any changes in the company's control or governance structure, nor will it affect the company's ongoing operations [2].